Cell Source Inc. Appoints CBIZ CPAs as New Auditor Following Marcum LLP's Resignation

Reuters
27 Jun
Cell Source Inc. Appoints CBIZ CPAs as New Auditor Following Marcum LLP's Resignation

Cell Source Inc. announced a change in its certifying accountant following the acquisition of Marcum LLP's attest business by CBIZ CPAs P.C. As of June 26, 2025, Marcum LLP resigned as the company's independent registered public accounting firm. Subsequently, CBIZ CPAs was engaged to take over for the fiscal year ending December 31, 2024, with the approval of Cell Source's Audit Committee. The company confirmed that there were no disagreements or reportable events with Marcum during the fiscal years 2022-2024 and the interim period leading up to the change. Marcum has been asked to provide a letter to the U.S. Securities and Exchange Commission confirming its agreement with these statements, which has been filed as part of Cell Source's regulatory disclosures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cell Source Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-016833), on June 27, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10